Celanese (CE) has just reported second quarter earnings that topped expectations, with stronger pricing, solid contributions from Engineered Materials and the Acetyl Chain, and management reaffirming full year earnings and free cash flow guidance.

Despite the earnings beat and a recent legal win in Amsterdam, Celanese shares trade at US$43.95 after a 1-day share price return of 1.88%. The 30-day share price return is down 9.72% and the 1-year total shareholder return is down 9.44%, pointing to mixed momentum, while the longer term 5-year total shareholder return is down 70.91%.

If Celanese’s latest move has you reassessing the chemicals space, it can help to widen your search and see what else is out there through 20 top founder-led companies

Celanese has just surprised on earnings, while the share price still reflects a long stretch of weak total returns. Does it make more sense to step in after this move, or to wait and see what the current valuation really implies?

Most Popular Narrative: 36% Undervalued

At a last close of $43.95 versus a narrative fair value of $68.70, Celanese is framed as materially undervalued, with that view hinging on specific growth and margin assumptions.

Strategic cost optimization such as supply chain consolidation, SKU rationalization, inventory reduction, and streamlined SG&A has materially lowered the company's fixed cost base, enhancing operating leverage and supporting higher EBITDA margins and net earnings when volumes recover.

Read the complete narrative. Read the complete narrative.

Want to see what sits behind that confidence in higher earnings power? The narrative leans on steady revenue gains, firmer margins, and a future earnings multiple below the broader chemicals sector. Curious how those moving parts stack up to reach that $68.70 fair value.

Result: Fair Value of $68.70 (UNDERVALUED)

However, Celanese still faces risks from weak demand and overcapacity in key acetyl and engineered materials markets, as well as elevated debt that could constrain future financial flexibility.

Next Steps

Given the mix of concerns and potential rewards around Celanese, it makes sense to look at the data directly and decide quickly where you stand. To weigh both sides in one place, start with the 3 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Celanese?

If Celanese has sharpened your focus on opportunities, do not stop here. Use the Simply Wall Street Screener to surface fresh ideas aligned with your goals.

• Target dependable compounding by scanning companies built around steady shareholder payouts through the 9 dividend fortresses.
• Spot potential mispricings by filtering for companies that combine quality fundamentals with appealing valuations using the 51 high quality undervalued stocks.
• Prioritise sleep-at-night holdings by concentrating on companies with sturdier financial profiles via the 78 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.